Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats

Experimental Eye Research

Volumn 106, Issue , 2013, Pages 64-73

  Mitsuhashi, Junko ^a   Morikawa, Shunichi ^a   Shimizu, Kazuhiko ^a   Ezaki, Taichi ^a   Yasuda, Yoshiko ^b   Hori, Sadao ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Basement membrane; Diabetic retinopathy; Erythropoietin; Experimental diabetes; Streptozotocin; Type IV collagen; VEGF

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; LECTIN; SODIUM CHLORIDE; STREPTOZOCIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EYE PROTECTION; IMMUNOFLUORESCENCE; MICROVASCULATURE; NONHUMAN; OPTIC DISK; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; RETINA; RETINA ARTERY; RETINA BLOOD FLOW; RETINA BLOOD VESSEL; RETINA CAPILLARY; RETINA VEIN; SINGLE DRUG DOSE; STAINING; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; CELL PROLIFERATION; COLLAGEN TYPE IV; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIUM, VASCULAR; ERYTHROPOIETIN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUORESCENT DYES; IMAGING, THREE-DIMENSIONAL; INTRAVITREAL INJECTIONS; MALE; PLANT LECTINS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ERYTHROPOIETIN; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RETINAL VESSELS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84870909984     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2012.11.001     Document Type: Article

References (46)

1. Adamis A.P., Miller J.W., Bernal M.T., D'Amico D.J., Folkman J., Yeo T.K., Yeo K.T. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 1994, 118:445-450.
2. Aiello L.M., Cavallerano J. Diabetic retinopathy. Curr. Ther. Endocrinol. Metab. 1997, 6:475-485.
3. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., Pasquale L.R., Thieme H., Iwamoto M.A., Park J.E., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 1994, 331:1480-1487.
4. Al-Gayyar M.M., Abdelsaid M.A., Matragoon S., Pillai B.A., El-Remessy A.B. Neurovascular protective effect of FeTPPs in N-methyl-D-aspartate model: similarities to diabetes. Am. J. Pathol. 2010, 177:1187-1197.
5. Anagnostou A., Liu Z., Steiner M., Chin K., Lee E.S., Kessimian N., Noguchi C.T. Erythropoietin receptor mRNA expression in human endothelial cells. Proc. Natl. Acad. Sci. U S A 1994, 91:3974-3978.
6. Bubner B., Baldwin I.T. Use of real-time PCR for determining copy number and zygosity in transgenic plants. Plant Cell. Rep. 2004, 23:263-271.
7. Chan P.S., Kanwar M., Kowluru R.A. Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory. J. Diabetes Complicat. 2010, 24:55-63.
8. Chen J., Connor K.M., Aderman C.M., Smith L.E. Erythropoietin deficiency decreases vascular stability in mice. J. Clin. Invest. 2008, 118:526-533.
9. Chen J., Connor K.M., Aderman C.M., Willett K.L., Aspegren O.P., Smith L.E. Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Invest. Ophthalmol. Vis. Sci. 2009, 50:1329-1335.
10. Chung H.K., Choi S.M., Ahn B.O., Kwak H.H., Kim J.H., Kim W.B. Efficacy of troxerutin on streptozotocin-induced rat model in the early stage of diabetic retinopathy. Arzneimittelforschung 2005, 55:573-580.
11. Cunha-Vaz J., Faria de Abreu J.R., Campos A.J. Early breakdown of the blood-retinal barrier in diabetes. Br. J. Ophthalmol. 1975, 59:649-656.
12. De La Cruz J.P., Gonzalez-Correa J.A., Guerrero A., de la Cuesta F.S. Pharmacological approach to diabetic retinopathy. Diabetes Metab. Res. Rev. 2004, 20:91-113.
13. Donnelly R., Emslie-Smith A.M., Gardner I.D., Morris A.D. ABC of arterial and venous disease: vascular complications of diabetes. BMJ 2000, 320:1062-1066.
14. Ezaki T., Baluk P., Thurston G., La Barbara A., Woo C., McDonald D.M. Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. Am. J. Pathol. 2001, 158:2043-2055.
15. Feit-Leichman R.A., Kinouchi R., Takeda M., Fan Z., Mohr S., Kern T.S., Chen D.F. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest. Ophthalmol. Vis. Sci. 2005, 46:4281-4287.
16. Gastinger M.J., Singh R.S., Barber A.J. Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Invest. Ophthalmol. Vis. Sci. 2006, 47:3143-3150.
17. Haefliger I.O., Zschauer A., Anderson D.R. Relaxation of retinal pericyte contractile tone through the nitric oxide-cyclic guanosine monophosphate pathway. Invest. Ophthalmol. Vis. Sci. 1994, 35:991-997.
18. Hammes H.P., Lin J., Renner O., Shani M., Lundqvist A., Betsholtz C., Brownlee M., Deutsch U. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 2002, 51:3107-3112.
19. Hernandez C., Fonollosa A., Garcia-Ramirez M., Higuera M., Catalan R., Miralles A., Garcia-Arumi J., Simo R. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema. Diabetes Care 2006, 29:2028-2033.
20. Inai T., Mancuso M., Hashizume H., Baffert F., Haskell A., Baluk P., Hu-Lowe D.D., Shalinsky D.R., Thurston G., Yancopoulos G.D., McDonald D.M. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am. J. Pathol. 2004, 165:35-52.
21. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol. Rev. 1992, 72:449-489.
22. Joussen A.M., Murata T., Tsujikawa A., Kirchhof B., Bursell S.E., Adamis A.P. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am. J. Pathol. 2001, 158:147-152.
23. Joussen A.M., Poulaki V., Le M.L., Koizumi K., Esser C., Janicki H., Schraermeyer U., Kociok N., Fauser S., Kirchhof B., Kern T.S., Adamis A.P. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004, 18:1450-1452.
24. Katsura Y., Okano T., Matsuno K., Osako M., Kure M., Watanabe T., Iwaki Y., Noritake M., Kosano H., Nishigori H., Matsuoka T. Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. Diabetes Care 2005, 28:2252-2254.
25. Kern T.S. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp. Diabetes Res. 2007, 2007:95103.
26. Kowluru R.A., Odenbach S. Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. Invest. Ophthalmol. Vis. Sci. 2004, 45:4161-4166.
27. Krantz S.B. Erythropoietin. Blood 1991, 77:419-434.
28. Kuwabara T., Cogan D.G. Retinal vascular patterns. VII. Acellular change. Invest. Ophthalmol. 1965, 4:1049-1064.
29. Masuda S., Nagao M., Takahata K., Konishi Y., Gallyas F., Tabira T., Sasaki R. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. J. Biol. Chem. 1993, 268:11208-11216.
30. Masuda S., Okano M., Yamagishi K., Nagao M., Ueda M., Sasaki R. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J. Biol. Chem. 1994, 269:19488-19493.
31. McVicar C.M., Hamilton R., Colhoun L.M., Gardiner T.A., Brines M., Cerami A., Stitt A.W. Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes 2011, 60:2995-3005.
32. Miller A.G., Smith D.G., Bhat M., Nagaraj R.H. Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions. J. Biol. Chem. 2006, 281:11864-11871.
33. Mizutani M., Kern T.S., Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J. Clin. Invest. 1996, 97:2883-2890.
34. Morikawa S., Ezaki T. Phenotypic changes and possible angiogenic roles of pericytes during wound healing in the mouse skin. Histol. Histopathol. 2011, 26:979-995.
35. Morishita E., Masuda S., Nagao M., Yasuda Y., Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997, 76:105-116.
36. Pfister F., Feng Y., vom Hagen F., Hoffmann S., Molema G., Hillebrands J.L., Shani M., Deutsch U., Hammes H.P. Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy. Diabetes 2008, 57:2495-2502.
37. Pierce E.A., Avery R.L., Foley E.D., Aiello L.P., Smith L.E. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. U S A 1995, 92:905-909.
38. Thurston G., Baluk P., Hirata A., McDonald D.M. Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. Am. J. Physiol. 1996, 271:H2547-H2562.
39. Ueda K., Nakahara T., Hoshino M., Mori A., Sakamoto K., Ishii K. Retinal blood vessels are damaged in a rat model of NMDA-induced retinal degeneration. Neurosci. Lett. 2010, 485:55-59.
40. Watanabe D., Suzuma K., Matsui S., Kurimoto M., Kiryu J., Kita M., Suzuma I., Ohashi H., Ojima T., Murakami T., Kobayashi T., Masuda S., Nagao M., Yoshimura N., Takagi H. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N. Engl. J. Med. 2005, 353:782-792.
41. Yamaji R., Okada T., Moriya M., Naito M., Tsuruo T., Miyatake K., Nakano Y. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur. J. Biochem. 1996, 239:494-500.
42. Yasuda Y., Sasaki T., Takagawa M., Maeda M., Yasuda M., Atsumi T., Fujita Y., Fujita H. Erythropoietin contributes to implantation: ectopic hemoglobin synthesis in decidual cells of mice. Congenit. Anom. Kyoto. 2007, 47:22-33.
43. Youssoufian H., Longmore G., Neumann D., Yoshimura A., Lodish H.F. Structure, function, and activation of the erythropoietin receptor. Blood 1993, 81:2223-2236.
44. Zhang J., Wu Y., Jin Y., Ji F., Sinclair S.H., Luo Y., Xu G., Lu L., Dai W., Yanoff M., Li W., Xu G.T. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest. Ophthalmol. Vis. Sci. 2008, 49:732-742.
45. Zhang S.X., Wang J.J., Dashti A., Wilson K., Zou M.H., Szweda L., Ma J.X., Lyons T.J. Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein. J. Mol. Endocrinol. 2008, 41:135-143.
46. Zhu Q., Xu X., Xia X., Gu Q., Ho P.C. Role of protein kinase C on the alteration of retinal endothelin-1 in streptozotocin-induced diabetic rats. Exp. Eye Res. 2005, 81:200-206.